{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-024444","form_type":"8-K","ticker":"XTNT","cik":"0001453593","company_name":"Xtant Medical Holdings, Inc.","filed_at":"2022-08-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.815130+00:00","generated_at":"2026-06-23T18:33:19.256106+00:00","sec_items":["3.02","5.02","8.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Xtant Medical closes $6.75M first tranche of private placement; appoints Vizirgianakis Chairman","bullets":["First tranche: sold 14.1M shares and warrants for 3.5M shares at ~$6.75M to accredited investors.","Second tranche of ~$3.0M (6.2M shares + 1.6M warrants) expected early October 2022.","Board expanded to 7 directors; Stavros Vizirgianakis elected Chairman, replacing Jeffrey Peters.","2022 Annual Meeting set for October 26, 2022; proxy materials to be mailed around September 20.","Net proceeds to support working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-024444","json":"https://secwatch.observer/filing/0001493152-22-024444.json","markdown":"https://secwatch.observer/filing/0001493152-22-024444.md","text":"https://secwatch.observer/filing/0001493152-22-024444.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/0001493152-22-024444-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T18:33:19.256106+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c89aa9d88","claim":"Stavros Vizirgianakis was appointed as Chairman of the Board at Xtant Medical Holdings, Inc..","evidence_excerpt":"the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/0001493152-22-024444-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"bafbb1da17","claim":"Jeffrey Peters changed role as Chairman of the Board at Xtant Medical Holdings, Inc..","evidence_excerpt":"the Board elected Mr. Vizirgianakis as Chairman of the Board, effective upon completion of the First Closing, to replace Jeffrey Peters, who previously served as Chairman of the Board and intends not to stand for re-election at the Company’s next annual meeting of stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/0001493152-22-024444-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"replaced"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}